First Republic Investment Management, Inc. Uro Gen Pharma Ltd. Transaction History

First Republic Investment Management, Inc.

  • $34.7 Billion
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 07, 2019
SELL
$32.75 - $40.35 $476,283 - $586,810
-14,543 Closed
0 $0
Q1 2019

Apr 30, 2019
BUY
$35.47 - $54.55 $10,392 - $15,983
293 Added 2.06%
14,543 $537,000
Q4 2018

Feb 12, 2019
SELL
$38.35 - $50.39 $623,187 - $818,837
-16,250 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$41.65 - $51.7 $166,600 - $206,800
4,000 Added 32.65%
16,250 $767,000
Q3 2017

Nov 14, 2017
BUY
$17.15 - $32.72 $210,087 - $400,820
12,250
12,250 $386,000

Others Institutions Holding URGN

# of Institutions
130
Shares Held
35.9M
Call Options Held
22K
Put Options Held
93.8K
View Full List

About UroGen Pharma Ltd.

URGN Quotes by TradingView
  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $254M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email